GH GUARDANT HEALTH INC
2026Q1 · CUSIP 40131M109 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
483
Δ holders QoQ
-13
Breadth percentile
Top 89%
Whale holders
207
Δ whales
-3
Inst. holding value
$12.5B
New positions
73
Closed positions
86
Price momentum (1Q)
-10.7%
Put / Call
12/10
Breadth history (34 quarters)
Past Lit Events & Aftermath 15 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 3% | -10.7% | — |
| 2025Q3 | Top 10% | +10.3% | +19.2% |
| 2025Q2 | Top 13% | +58.7% | +80.6% |
| 2025Q1 | Top 4% | +45.6% | +139.8% |
| 2024Q4 | Top 19% | -16.6% | +21.3% |
| 2024Q2 | Top 8% | +8.1% | +75.3% |
| 2023Q2 | Top 10% | -30.3% | -37.1% |
| 2020Q4 | Top 7% | -35.0% | -42.9% |
Options Sentiment
Put holders
12
QoQ: -1
Call holders
10
QoQ: -5
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.40
EPS YoY
—
Revenue (TTM)
$1.1B
Revenue YoY
+39.6%
Net margin
-40.1%
ROE
—
Debt ratio
109.5%
FCF (TTM)
-$237M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.